Abstract:Transcription factors are key mediators of human complex disease processes. Identifying the target genes of transcription factors will increase our understanding of the biological network leading to disease risk. The prediction of transcription factor binding sites (TFBSs) is one method to identify these target genes; however, current prediction methods need improvement. We chose the transcription factor upstream stimulatory factor l (USF1) to evaluate the performance of our novel TFBS prediction method because of its known genetic association with coronary artery disease (CAD) and the recent availability of USF1 chromatin immunoprecipitation microarray (ChIP-chip) results. The specific goals of our study were to develop a novel and accurate genome-scale method for predicting USF1 binding sites and associated target genes to aid in the study of CAD. Previously published USF1 ChIP-chip data for 1 per cent of the genome were used to develop and evaluate several kernel logistic regression prediction models. A combination of genomic features (phylogenetic conservation, regulatory potential, presence of a CpG island and DNaseI hypersensitivity), as well as position weight matrix (PWM) scores, were used as variables for these models. Our most accurate predictor achieved an area under the receiver operator characteristic curve of 0.827 during cross-validation experiments, significantly outperforming standard PWM-based prediction methods. When applied to the whole human genome, we predicted 24,010 USF1 binding sites within 5 kilobases upstream of the transcription start site of 9,721 genes. These predictions included 16 of 20 genes with strong evidence of USF1 regulation. Finally, in the spirit of genomic convergence, we integrated independent experimental CAD data with these USF1 binding site prediction results to develop a prioritised set of candidate genes for future CAD studies. We have shown that our novel prediction method, which employs genomic features related to the presence of regulatory elements, enables more accurate and efficient prediction of USF1 binding sites. This method can be extended to other transcription factors identified in human disease studies to help further our understanding of the biology of complex disease.

Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction

Transcriptional landscape of a hypoxia response identifies cell-specific pathways for adaptation

Identification of small molecule compounds that inhibit the HIF-1 signaling pathway

Genome-wide identification of the regulatory targets of a transcription factor using biochemical characterization and computational genomic analysis

Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators

Identifying transcription factor binding sites through Markov chain optimization

Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells

High-throughput screening identifies CHMP4A associated with hypoxia-inducible factor 1

Computational identification of transcription factor binding sites by functional analysis of sets of genes sharing overrepresented upstream motifs

Targeted Genes and Interacting Proteins of Hypoxia Inducible Factor-1.

Identification of Heme Oxygenase-1 as a Putative DNA-Binding Protein

A Microfluidics-Based Platform For Identification And Detailed Characterization Of Transcription Factor Binding Sites

Understanding Transcription Factor Regulation by Integrating Gene Expression and DNase I Hypersensitive Sites

Identification of Chemical Compounds That Induce HIF-1alpha Activity.

CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data

Finding the Genes Underlying Adaptation to Hypoxia Using Genomic Scans for Genetic Adaptation and Admixture Mapping

Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer

Identification of a Novel Small-Molecule Inhibitor of the Hypoxia-Inducible Factor 1 Pathway

Using β-Lactamase and NanoLuc Luciferase Reporter Gene Assays to Identify Inhibitors of the HIF-1 Signaling Pathway

RIP: the regulatory interaction predictor—a machine learning-based approach for predicting target genes of transcription factors

A general integrative genomic feature transcription factor binding site prediction method applied to analysis of USF1 binding in cardiovascular disease